[{"AccountsPayableCurrent_0_Q2_USD":20697000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-317000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-436000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":15.41,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":16506000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":36368000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":15000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":41240000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":11092000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":938000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":5059000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":8321000.0,"OtherIndefiniteLivedIntangibleAssets_0_Q2_USD":15378000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5253000.0,"MarketableSecuritiesCurrent_0_Q2_USD":276898000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":309030000.0,"EarningsPerShareDiluted_2_Q2_USD":0.6,"EarningsPerShareDiluted_1_Q2_USD":0.3,"SellingAndMarketingExpense_2_Q2_USD":34245000.0,"NonoperatingIncomeExpense_1_Q2_USD":90000.0,"NonoperatingIncomeExpense_2_Q2_USD":1005000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":160000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":202000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":57.26,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":9343000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":53129000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":53022000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":15093000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":115000000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":224325000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":621000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":9523000.0,"LineOfCreditFacilityInterestRateAtPeriodEnd_0_Q2_pure":0.0119,"SellingAndMarketingExpense_1_Q2_USD":17729000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":275000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":278000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":555000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1277000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":444000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1062000.0,"OperatingLeasePayments_2_Q2_USD":643000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1540000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.031,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":2350000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":308524000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":12658000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":224325000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":115000000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":1511000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":3192000.0,"ShortTermLeaseCost_1_Q2_USD":16000.0,"ShortTermLeaseCost_2_Q2_USD":60000.0,"TradingSecuritiesDebt_0_Q2_USD":276898000.0,"OperatingLeaseLiability_0_Q2_USD":1507000.0,"Goodwill_0_Q2_USD":111687000.0,"OperatingLeaseCost_2_Q2_USD":645000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"AccrualForEnvironmentalLossContingencies_0_Q2_USD":916000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":47598000.0,"DebtSecuritiesTradingUnrealizedGain_2_Q2_USD":424000.0,"DebtSecuritiesTradingUnrealizedLoss_2_Q2_USD":151000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":45269000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":6020000.0,"LeaseCost_1_Q2_USD":456000.0,"LeaseCost_2_Q2_USD":705000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1608000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":44000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":169000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":613000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":101000.0,"LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_2_Q2_USD":0.0,"OperatingLeaseCost_1_Q2_USD":440000.0,"EarningsPerShareBasic_2_Q2_USD":0.6,"EarningsPerShareBasic_1_Q2_USD":0.3,"CostOfGoodsAndServicesSold_2_Q2_USD":120809000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-6662000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2080000.0,"InventoryNet_0_Q2_USD":92529000.0,"Liabilities_0_Q2_USD":68231000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":845626000.0,"LiabilitiesCurrent_0_Q2_USD":44587000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":12658000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-12936000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":47524000.0,"NetIncomeLoss_1_Q2_USD":15885000.0,"NetIncomeLoss_2_Q2_USD":31745000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15201000.0,"ProfitLoss_1_Q2_USD":15885000.0,"ProfitLoss_2_Q2_USD":31745000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":83774000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":7400000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":510467000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3450000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":19335000.0,"AccountsReceivableNetCurrent_0_Q2_USD":79931000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":476000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-15086000.0,"AdditionalPaidInCapital_0_Q2_USD":273495000.0,"Assets_0_Q2_USD":845626000.0,"AssetsCurrent_0_Q2_USD":578426000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":113867000.0,"CommonStockSharesIssued_0_Q2_shares":53244057.0,"CommonStockSharesOutstanding_0_Q2_shares":53244057.0,"CommonStockValue_0_Q2_USD":8519000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":352000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":12184000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":23197000.0,"GrossProfit_1_Q2_USD":53214000.0,"GrossProfit_2_Q2_USD":103516000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":39145000.0,"TradingSecuritiesDebtAmortizedCost_0_Q2_USD":276625000.0,"StockholdersEquity_0_Q2_USD":777395000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.16,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":53300000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1350000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":18391000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-5581000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-4063000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":444000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":54821000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-465000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-272000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":1910000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":59.29,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":42.04,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":68.47,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":777395000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":61786000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":53404000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":294000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.313,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":48546000.0,"OperatingExpenses_1_Q2_USD":33969000.0,"OperatingExpenses_2_Q2_USD":65376000.0,"OperatingIncomeLoss_1_Q2_USD":19245000.0,"OperatingIncomeLoss_2_Q2_USD":38140000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":1.0,"PreferredStockSharesAuthorized_0_Q2_shares":100000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4056000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":7934000.0,"ShareBasedCompensation_2_Q2_USD":3192000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.002,"EntityCommonStockSharesOutstanding_0_Q2_shares":53244057.0,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20201130","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20201229"}]